Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating immune cells in multiple sclerosis.
Jones AP, Kermode AG, Lucas RM, Carroll WM, Nolan D, Hart PH. Jones AP, et al. Among authors: kermode ag. Clin Exp Immunol. 2017 Feb;187(2):193-203. doi: 10.1111/cei.12878. Epub 2016 Nov 2. Clin Exp Immunol. 2017. PMID: 27689339 Free PMC article. Review.
A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study.
Hart PH, Jones AP, Trend S, Cha L, Fabis-Pedrini MJ, Cooper MN, d'Este C, Geldenhuys S, Carroll WM, Byrne SN, Booth DR, Cole JM, Lucas RM, Kermode AG. Hart PH, et al. Among authors: kermode ag. Mult Scler J Exp Transl Clin. 2018 Apr 27;4(2):2055217318773112. doi: 10.1177/2055217318773112. eCollection 2018 Apr-Jun. Mult Scler J Exp Transl Clin. 2018. PMID: 29780610 Free PMC article.
IgG3 + B cells are associated with the development of multiple sclerosis.
Marsh-Wakefield F, Ashhurst T, Trend S, McGuire HM, Juillard P, Zinger A, Jones AP, Kermode AG, Hawke S, Grau GE, Hart PH, Byrne SN. Marsh-Wakefield F, et al. Among authors: kermode ag. Clin Transl Immunology. 2020 Apr 29;9(5):e01133. doi: 10.1002/cti2.1133. eCollection 2020 May. Clin Transl Immunology. 2020. PMID: 32355561 Free PMC article.
Prediction of multiple sclerosis outcomes when switching to ocrelizumab.
Zhong M, van der Walt A, Stankovich J, Kalincik T, Buzzard K, Skibina O, Boz C, Hodgkinson S, Slee M, Lechner-Scott J, Macdonell R, Prevost J, Kuhle J, Laureys G, Van Hijfte L, Alroughani R, Kermode AG, Butler E, Barnett M, Eichau S, van Pesch V, Grammond P, McCombe P, Karabudak R, Duquette P, Girard M, Taylor B, Yeh W, Monif M, Gresle M, Butzkueven H, Jokubaitis VG. Zhong M, et al. Among authors: kermode ag. Mult Scler. 2022 May;28(6):958-969. doi: 10.1177/13524585211049986. Epub 2021 Oct 8. Mult Scler. 2022. PMID: 34623947
198 results